The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Top Cited Papers
Open Access
- 14 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (20) , 4918-4921
- https://doi.org/10.1182/blood-2008-08-174110
Abstract
Unique and shared cytogenetic abnormalities have been documented for marginal zone lymphomas (MZLs) arising at different sites. Recently, homozygousKeywords
This publication has 21 references indexed in Scilit:
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation‐negative MALT lymphoma of the ocular adnexa and salivary glandsThe Journal of Pathology, 2008
- T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20Nature Immunology, 2008
- Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaLeukemia, 2007
- The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genesProceedings of the National Academy of Sciences, 2007
- TNFAIP3 is the target gene of chromosome band 6q23.3‐q24.1 loss in ocular adnexal marginal zone B cell lymphomaGenes, Chromosomes and Cancer, 2007
- Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implicationsBlood, 2006
- Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphomaThe Journal of Experimental Medicine, 2006
- Delving deeper into MALT lymphoma biology.Journal of Clinical Investigation, 2005
- A20 inhibits NF-κB activation by dual ubiquitin-editing functionsTrends in Biochemical Sciences, 2005